Home >> Chemicals Listing >> hot product list by 1  

1-Propanamine,3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (1:1) (6202-23-9)

Identification
Name:1-Propanamine,3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (1:1)
Synonyms:1-Propanamine,3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (9CI);5H-Dibenzo[a,d]cycloheptene-D5,g-propylamine, N,N-dimethyl-,hydrochloride (6CI,7CI,8CI); 10,11d-Amitriptyline hydrochloride; Benzamin; Cyclobenzaprine hydrochloride;Flexeril; Flexiban; Lisseril; MK 130 hydrochloride; Miosan; Proheptatrienehydrochloride; Tensodox; Yurelax
CAS:6202-23-9
EINECS: 228-264-4
Molecular Formula: C20H21N.HCl
Molecular Weight: 311.88
InChI: InChI=1/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H
Molecular Structure: (C20H21N.HCl) 1-Propanamine,3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (9CI);5H-Dibenzo...
Properties
Transport:UN 2811 6.1/PG 3
Melting Point: 216-2180C
Appearance:Crystalline Solid
Specification:

The Cyclobenzaprine hydrochloride with the cas number 6202-23-9, is also called (1)Amrix ; (2) Cloben ; (3) Cyben ; (4) Cyclobenzaprine HCl ; (5) Cyclobenzaprine hydrochloride ; (6) Cycloflex ; (7) Flexeril ; (8) Flexiban ; (9) Lisseril ; (10) MK 130 hydrochloride ; (11) Novo-Cycloprine ; (12) Proheptatrien monohydrochloride ; (13) Proheptatriene hydrochloride ; (14) Proheptatriene monohydrochloride ; (15) Tabradol ; (16) Tensodox ; (17) UNII-0VE05JYS2P ; (18) 1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride 10,11deltaAmitriptyline hydrochloride ; (19) 5-(3-Dimethylaminopropylidene)-5H-dibenzo-(a,d)cycloheptene hydrochloride;(20)N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine hydrochloride. Cyclobenzaprine hydrochloride belongs to the following Product Categories: Heterocyclic Compounds;Intermediates & Fine Chemicals;Pharmaceuticals and so on.

Properties of Cyclobenzaprine hydrochloride are: (1)ACD/BCF (pH 5.5): 3.76 ; (2)ACD/BCF (pH 7.4): 66.96 ; (3)ACD/KOC (pH 5.5): 12.66 ; (4)ACD/KOC (pH 7.4): 225.6 ; (5)#H bond acceptors: 1 ; (6)#H bond donors: 0 ; (7)Flash Point: 177.8 °C ; (8)Enthalpy of Vaporization: 65.76 kJ/mol ; (9)Boiling Point: 405.9 °C at 760 mmHg ; (10)Vapour Pressure: 8.45E-07 mmHg at 25°C

Uses of Cyclobenzaprine hydrochloride: Cyclobenzaprine hydrochloride is a muscle relaxant, which is prescribed to relieve muscle spasms caused by injuries such as strains sprains, pulls. Combined with rest and physical therapy, it provides clinical relief of muscular stiffness and pain. Cyclobenzaprine hydrochloride is also can be used as reactant to obtain 5-[3-(N-Carbethoxy-N-methylamino)-propyliden]-dibenzo[a,d]cyclohepten. Cyclobenzaprine hydrochloride react with carbonochloridic acid ethyl ester with heating for 6 hour(s) in the toluene solvent.
                            

You can still convert the following datas into molecular structure :
1. SMILES: Cl.c3cc\2c(\C=C/c1c(cccc1)C/2=C/CCN(C)C)cc3
2. InChI: InChI=1/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H

The Cyclobenzaprine hydrochloride toxic data can be showed in the following sheet.

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo oral 5714ug/kg/2D- (5.714mg/kg) BEHAVIORAL: WAKEFULNESS

BEHAVIORAL: EUPHORIA

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
Journal of Clinical Psychiatry. Vol. 54, Pg. 39, 1993.
mouse LD50 intravenous 36mg/kg (36mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 144, Pg. 481, 1963.
mouse LD50 oral 250mg/kg (250mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 87, 1972.
women TDLo oral 1mg/kg/3D-I (1mg/kg) BEHAVIORAL: WAKEFULNESS

BEHAVIORAL: EUPHORIA

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
Journal of Clinical Psychiatry. Vol. 54, Pg. 39, 1993.
women TDLo oral 8400ug/kg/2W- (8.4mg/kg) BEHAVIORAL: GENERAL ANESTHETIC Journal of Clinical Psychiatry. Vol. 44, Pg. 151, 1983.
women TDLo oral 12mg/kg (12mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 281, 1983.

Packinggroup: III
Usage:Use as muscle relaxant (skeletal)
Safety Data
Hazard Symbols Xn: Harmful
 

Other Product